CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in CASI Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −6 vs. Q3 2025
- Shares held
- 1.25M
- −1.36M (−52.0%) vs. Q3 2025
- Total value
- $1.06M
- −$3.26M (−75.4%) vs. Q3 2025
- New holders
- 1
- 2 more added
- Sold out
- 7
- 5 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 987,259 | $839.2K | 0.04% | 00.0% | Unchanged |
| Woodline Partners LP | 133,406 | $113.4K | 0.00% | −32,234−19.5% | Reduced |
| Renaissance Technologies LLC | 43,100 | $36.6K | 0.00% | −800−1.8% | Reduced |
| Two Sigma Investments, LP | 23,787 | $20.2K | 0.00% | −9,480−28.5% | Reduced |
| Bank of America Corp | 19,935 | $16.9K | 0.00% | −234,949−92.2% | Reduced |
| Geode Capital Management, LLC | 18,808 | $16.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,045 | $11.9K | 0.00% | +14,045 | New |
| Royal Bank of Canada | 9,950 | $8.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 659 | $560 | 0.00% | +645+4,607.1% | Added |
| Wells Fargo & Company | 505 | $429 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 367 | $312 | 0.00% | +2+0.5% | Added |
| BNP Paribas Arbitrage, SA | 134 | $114 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 133 | $113 | 0.00% | −12−8.3% | Reduced |
| JPMorgan Chase & Co | 25 | $21 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $9 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 5 | $5 | 0.00% | 00.0% | Unchanged |
| Foresite Capital Management VI LLC | 0 | $0 | 0.00% | −979,956−100.0% | Sold out |
| Wellington Shields Capital Management, LLC | 0 | $0 | 0.00% | −69,535−100.0% | Sold out |
| Wellington Shields & Co., LLC | 0 | $0 | 0.00% | −30,091−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −10,135−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −296−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −13−100.0% | Sold out |